Coronavirus (COVID-19) Update: FDA Authorizes Additional Oral Antiviral for Treatment of COVID-19 in Certain Adults

The FDA issued an emergency use authorization for Merck ’s molnupiravir for the treatment of mild-to-moderate COVID-19 in certain adults.

Source: FDA Center for Drug Evaluation and Research - What's New - December 23, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news